Document Detail


Long-term, antidiabetogenic effects of GLP-1 gene therapy using a double-stranded, adeno-associated viral vector.
MedLine Citation:
PMID:  20720576     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Diabetes is characterized by insulin resistance and a reduction in insulin secretion, leading to progressive β-cell failure and loss of β-cell mass. Its central therapeutic issues are how to restore glucose responsiveness of β-cells to normal and counteract defects in insulin secretion. Native glucagon-like peptide-1 (GLP-1), which makes β-cells competent and diabetic β-cells specifically more sensitive to glucose, has a major drawback of rapid inactivation. In this study, we describe the construction and analysis of a GLP-1 plasmid and double-stranded, adeno-associated viral (dsAAV) expression vector to overcome both the rapid degradation of native GLP-1 and limitations of gene therapy using standard single-stranded AAV. Our study results demonstrate that fasting blood glucose levels of db/db obese mice decreased significantly up to 4 months after a single injection of dsAAV GLP-1, and both insulin and circulating GLP-1 levels increased in dsAAV GLP-1-infected mice. These results demonstrate that dsAAV GLP-1 has long-term, efficient transgene expression with minimal toxicity and cellular immune responses. This study suggests that GLP-1 produced by dsAAV may be an alternative to the continuous infusions required for GLP-1 peptide therapy or daily injections of GLP-1.
Authors:
S H Choi; H C Lee
Related Documents :
18366986 - Exenatide as a treatment for diabetes and obesity: implications for cardiovascular risk...
19366866 - Association of type 2 diabetes candidate polymorphisms in kcnq1 with incretin and insul...
11845326 - Over-expression of the glucagon-like peptide-1 receptor on ins-1 cells confers autocrin...
10484306 - Ileal [correction of ilial] transposition and enteroglucagon/glp-1 in obesity (and diab...
15775796 - Long-term treatment with losartan versus atenolol improves insulin sensitivity in hyper...
18541546 - The effect of meal replacements high in glycomacropeptide on weight loss and markers of...
Publication Detail:
Type:  Journal Article     Date:  2010-08-19
Journal Detail:
Title:  Gene therapy     Volume:  18     ISSN:  1476-5462     ISO Abbreviation:  Gene Ther.     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-02-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9421525     Medline TA:  Gene Ther     Country:  England    
Other Details:
Languages:  eng     Pagination:  155-63     Citation Subset:  IM    
Affiliation:
Department of Endocrinology and Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Inhibition of the IKK/NF-?B pathway by AAV gene transfer improves muscle regeneration in older mdx m...
Next Document:  Metabolically stabilized long-circulating PEGylated polyacridine peptide polyplexes mediate hydrodyn...